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Posterior cingulate cortex in Alzheimer’s
disease
SiR-In the living brain of patients with Alzheimer’s disease,
positron emission tomography with 18 F-fluorodeoxyglucose
(FDG) reveals characteristic hypometabolism in neocortical
structures, especially in parietal, temporal, and frontal
association cortex, the same locations where co-existing
neuronal degeneration is revealed postmortemY Neuronal
degeneration is also found in the limbic system, a structure
closely related to memory and other cognitive processes, but
corresponding metabolic abnormalities have not been
emphasised by in-vivo imaging.
Using new image-processing technology, we found severe
metabolic reduction in the posterior cingulate cortex in
Alzheimer’s disease. FDG images from positron emission
tomography in 37 patients with probable Alzheimer’s disease
and 22 normal controls were transformed anatomically to
the uniform shape of a standard stereotactic atlas brain while
preserving regional metabolic information. 3 Metabolic
activities of lateral and medial brain structures were
extracted from the images, averaged within each group, and
compared with t statistics. Statistical surface-projection
maps demonstrated metabolic reduction in the posterior
cingulate cortex, which was as significant as that in the
parietotemporal neocortex (figure). The metabolic reduction
in the posterior cingulate cortex correlated most closely with
reductions in the medial parietal cortex, followed by those in
the lateral parietal cortex. In addition, the metabolic
reduction in the posterior cingulate cortex was present in 3
patients with Alzheimer’s disease who were only
questionably demented at the time of scanning.
The metabolic reduction in the posterior cingulate cortex
is strong evidence of abnormalities of energy metabolism
involving the limbic system and is consistent with underlying
neuronal degeneration in the posterior cingulate cortex in
Alzheimer’s disease.2 Metabolic correlation between the
posterior cingulate cortex and the parietal cortex may be due
to neuronal interconnections.4 Interestingly, the anterior
cingulate cortex which has distinct connections and
Figure: Three-dimensional views of cerebral metabolic
reduction in Alzheimer’s disease
Areas of statistically significant metabolic reduction (p<0’05 adjusted
for multiple comparisons) superimposed on brain surface images of each
hemisphere. Colour scale indicates degree of significance
(red>yellow>green). On lateral views (top), panetal, temporal, and
frontal neocortex show hypometabolism. Note concordance between
pattern of hypometabolic regions and that of neuronal degeneration
previously reported.’ On medial views (bottom), posterior cingulate
cortex (arrows), cinguloparietal transition area, and medial parietal
cortex show metabolic reduction. No such abnormalities were present in
anterior cmgulate cortex.
behavioural attributes from those of the posterior cingulate
cortex, was spared, as it is histopathologically.2 The cause of
abnormal energy metabolism in the posterior cingulate
circuit and its functional significance in cognitive
dysfunctions in Alzheimer’s disease need further
investigation. Detection of metabolic and possibly
neurochemical abnormalities5 in the posterior cingulate
cortex could enhance accuracy in early in-vivo diagnosis of
Alzheimer’s disease.
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The global challenge of tuberculosis
SIR-In your July 30 editorial on tuberculosis you state that
by far the largest share of tuberculosis cases is in developing
countries and that "estimates suggest that fewer than half the
patients ... are in contact with treatment services". Further
on, you review the topics tackled by the new "flurry of
research after two decades of neglect": development of new
drugs, rapid molecular diagnostic techniques. As others have
done,’ you give the impression that further technological
advances will provide the answer to this global challenge. We
consider this is a rather narrow basis for selecting research
priorities.
Case-finding and treatment remain the cornerstone of
tuberculosis control. Improved diagnostic and therapeutic
techniques may indeed help to reduce some of the leakage
between occurrence of tuberculosis and cure. However, as
M Piot of WHO pointed out in the early 1960s, there are a
series of potential bottlenecks. Patients with tuberculosis
may or may not contact treatment services; those who do so
might not be identified as cases of tuberculosis; those that
are identified may not be prescribed treatment; those that
are prescribed treatment might not be able to obtain it; those
that obtain treatment may fail to complete treatment; and
treatment may fail to cure some of those who complete the
prescribed regimen. Successful cure can be achieved only if
these possible points of leakage are overcome.
Specifically, increasing treatment efficacy will only have a
marginal effect if major leakage occurs at all the preceding
steps; this seems to be the case not only in developing
countries, but also in parts of the industrialised world.
Surprisingly little headway has been made over past decades
in issues such as integration of tuberculosis control activities,
the development of strategies to improve patient compliance
and ensure continuity of care, or the crucial issue of financial
access to treatment.
I hope that The Lancet’s September, 1995, conference in
Washington will not be devoted exclusively to the biological
aspects of the resurgence of tuberculosis. Behavioural and
